← Back to Search

Quality Improvement Strategies for Acute Coronary Syndrome

N/A

Recruiting

Led By Julian Hertz, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years or older

History of myocardial infarction

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days after enrollment

Awards & highlights

Study Summary

This trial will study ways to improve evidence-based care for people with acute coronary syndrome in Tanzania by surveying patients, providers, and administrators. Data used to develop a quality improvement program which will be tested 6 months later.

Who is the study for?

This trial is for adults over 18 who have symptoms of acute coronary syndrome (ACS) or a history of heart attack, can communicate in Swahili or English, and are clinically stable. It's not suitable for those who are medically unstable, deteriorating, or too critically ill to participate.Check my eligibility

What is being tested?

The study aims to develop a program that improves care for patients with ACS at KCMC in Tanzania. It involves surveys and interviews with patients, healthcare providers, and administrators both before and six months after implementing the new quality improvement intervention.See study design

What are the potential side effects?

Since this trial focuses on developing a quality improvement intervention rather than testing medications or medical procedures directly, it does not involve typical medication side effects. However, participants may experience discomfort when discussing their health experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have had a heart attack before.

Select...

I am experiencing symptoms of a heart attack.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ initial ed visit (baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~initial ed visit (baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and initial ed visit (baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability as measured by the Acceptability of Intervention Measure (AIM)

Secondary outcome measures

Aspirin administration

Patients presenting with chest pain or shortness of breath who undergo ECG and cardiac biomarker testing during their ED stay

Patients with ACS taking aspirin 30 days after enrollment

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: MI Patients in northern TanzaniaExperimental Treatment1 Intervention

Patients presenting to KCMC emergency department with acute MI

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,364 Previous Clinical Trials

3,420,242 Total Patients Enrolled

6 Trials studying Acute Coronary Syndrome

25,311 Patients Enrolled for Acute Coronary Syndrome

Julian Hertz, MDPrincipal InvestigatorDuke University Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being recruited to take part in this experiment?

"Indeed, the information hosted on clinicaltrials.gov suggests that this trial is actively recruiting participants. The experiment was first announced on September 1st 2023 and has been altered most recently on September 6th 2023. A total of 400 individuals need to be recruited from one medical centre for full completion of the study."

Answered by AI

Has recruitment for this experiment commenced?

"According to details on clinicaltrials.gov, this medical trial is actively enrolling patients. The investigation was first uploaded on September 1st 2023 and has been amended as recently as the 6th of that same month."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Acute Coronary Syndrome KCMC

2023. "Acute Coronary Syndrome KCMC". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04563546.